Assessing blinding methodology in multiple sclerosis clinical trials

被引：0
|
作者：
Scalfari, A. [1 ]
机构：
[1] Univ Oxford, Oxford, England
来源：
MULTIPLE SCLEROSIS | 2006年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S92 / S92
页数：1
相关论文
共 50 条
  • [1] Methodology of clinical trials in multiple sclerosis
    Mitsikostas, D. D.
    [J]. NEUROLOGICAL SCIENCES, 2006, 27 (Suppl 5) : S362 - S364
  • [2] Methodology of clinical trials in multiple sclerosis
    D. D. Mitsikostas
    [J]. Neurological Sciences, 2006, 27 : s362 - s364
  • [3] Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting
    Tur, Carmen
    Moccia, Marcello
    Barkhof, Frederik
    Chataway, Jeremy
    Sastre-Garriga, Jaume
    Thompson, Alan J.
    Ciccarelli, Olga
    [J]. NATURE REVIEWS NEUROLOGY, 2018, 14 (02) : 75 - 93
  • [4] Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting
    Carmen Tur
    Marcello Moccia
    Frederik Barkhof
    Jeremy Chataway
    Jaume Sastre-Garriga
    Alan J. Thompson
    Olga Ciccarelli
    [J]. Nature Reviews Neurology, 2018, 14 : 75 - 93
  • [5] Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
    Jadad, AR
    Moore, RA
    Carroll, D
    Jenkinson, C
    Reynolds, DJM
    Gavaghan, DJ
    McQuay, HJ
    [J]. CONTROLLED CLINICAL TRIALS, 1996, 17 (01): : 1 - 12
  • [6] Assessing efficacy in clinical trials of treatments for multiple sclerosis - Issues and controversy
    Waubant, EL
    Goodkin, DE
    [J]. CNS DRUGS, 1996, 6 (06) : 462 - 473
  • [7] Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials
    Sormani, Maria Pia
    Pardini, Matteo
    [J]. NEUROTHERAPEUTICS, 2017, 14 (04) : 924 - 933
  • [8] Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials
    Maria Pia Sormani
    Matteo Pardini
    [J]. Neurotherapeutics, 2017, 14 : 924 - 933
  • [9] Assessment of blinding in clinical trials
    Bang, HJ
    Ni, LY
    Davis, CE
    [J]. CONTROLLED CLINICAL TRIALS, 2004, 25 (02): : 143 - 156
  • [10] TREATMENT OF MULTIPLE-SCLEROSIS WITH IVIG - POTENTIAL EFFECTS AND METHODOLOGY OF CLINICAL-TRIALS
    SORENSEN, PS
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 : 62 - 64
12345